{
    "shots": [
        {
            "query": "Subjects received one tablet twice daily in accordance with dosage recommended by the German Commission E (Blumenthal and Busse, 1998).",
            "answer": "{\"FREQUENCY\": [\"twice daily\"]}"
        },
        {
            "query": "Since the clinical therapeutic dosage of warfarin in common use was 1\u20132\u00a0mg/day for a person, the equivalent rats dosage was calculated to be 0.2\u00a0mg/kg (human equivalent dosage in rat\u00a0=\u00a0human dosage/60\u00a0kg\u00a0\u00d7\u00a06.2), once daily [38].",
            "answer": "{\"FREQUENCY\": [\"once daily\"]}"
        },
        {
            "query": "plus placebo once daily Placebo, placebo b.i.d.",
            "answer": "{\"FREQUENCY\": [\"once daily\"]}"
        },
        {
            "query": "For clinical study, healthy human volunteers received a single dose of DEX alone (phase-I) and repeated the same dose after a washout period and four-day Asafetida treatment (phase-II).",
            "answer": "{\"FREQUENCY\": [\"single dose\"]}"
        },
        {
            "query": "The clinical use of gliclazide is initiated at 40\u2009mg daily and may increase up to 320\u2009mg daily in divided doses.",
            "answer": "{\"FREQUENCY\": [\"daily\", \"daily\"]}"
        }
    ]
}